Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 2/20 | 0.35 |
| ▸ | HTR2B | P41595 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 2/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12085764 | 1.00 | ALOX12 (0.36) | ALOX12HTR2CHTR2BHTR2ACNR2 | |
| SCHEMBL10110283 | 1.00 | ALOX12 (0.36) | ALOX12HTR2CHTR2BHTR2ACNR2 | |
| SCHEMBL18120574 | 0.77 | SLC6A2 (0.39) | HTR2CHTR2BHTR2ASLC6A2SLC6A3 | |
| SCHEMBL16709143 | 0.72 | ALOX12 (0.40) | ALOX12HTR2CHTR2BHTR2ACNR2 | |
| SCHEMBL10034155 | 0.71 | ALOX12 (0.39) | ALOX12HTR2CHTR2BHTR2ACNR2 | |
| SCHEMBL10110280 | 0.66 | — | — | |
| SCHEMBL12436168 | 0.66 | — | — | |
| SCHEMBL13731873 | 0.64 | GAA (0.43) | ALOX12HTR2CHTR2BHTR2ACNR2 | |
| SCHEMBL13875974 | 0.64 | ALDH1A1 (0.39) | ALOX12HTR2CHTR2BHTR2AGAA | |
| SCHEMBL13875971 | 0.64 | HTR2C (0.35) | ALOX12HTR2CHTR2BHTR2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11778898-B2 | Carbene metal complexes as OLED materials | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-10-03 | — | — | US | disclosed |
| US-11778898-B2 | Carbene metal complexes as OLED materials | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-10-03 | — | — | US | disclosed |
| US-20190189937-A1 | Carbene Metal Complexes as OLED Materials | UNIV SOUTHERN CALIFORNIA (US) | 2019-06-20 | — | — | US | disclosed |
| US-10249834-B2 | Carbene metal complexes as OLED materials | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2019-04-02 | — | — | US | disclosed |
| US-20160293864-A1 | ORGANIC ELECTROLUMINESCENT DEVICES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-10-06 | — | — | US | disclosed |
| US-20160268518-A1 | Carbene Metal Complexes as OLED Materials | UNIV SOUTHERN CALIFORNIA (US) | 2016-09-15 | — | — | US | disclosed |
| US-20160268518-A1 | Carbene Metal Complexes as OLED Materials | UNIV SOUTHERN CALIFORNIA (US) | 2016-09-15 | — | — | US | disclosed |
| US-9356245-B2 | Carbene metal complexes as OLED materials | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-31 | — | — | US | disclosed |
| US-9356245-B2 | Carbene metal complexes as OLED materials | UNIVERSAL DISPLAY CORPORATION (US) | 2016-05-31 | — | — | US | disclosed |
| US-8728632-B2 | Metal complexes comprising bridged carbene ligands and use thereof in OLEDs | BASF SE (DE) | 2014-05-20 | — | — | US | disclosed |
| US-20120104378-A1 | CARBENE METAL COMPLEXES AS OLED MATERIALS | DJUROVICH PETER (US) | 2012-05-03 | — | — | US | disclosed |
| US-8114533-B2 | Carbene metal complexes as OLED materials | UNIVERSAL DISPLAY CORPORATION (US) | 2012-02-14 | — | — | US | disclosed |
| US-8114533-B2 | Carbene metal complexes as OLED materials | UNIVERSAL DISPLAY CORPORATION (US) | 2012-02-14 | — | — | US | disclosed |
| US-20100264405-A1 | TRANSITION METAL COMPLEXES WITH BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | BASF SE (DE) | 2010-10-21 | — | — | US | disclosed |
| US-20100213834-A1 | TRANSITION METAL COMPLEXES COMPRISING BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | BASF SE (DE) | 2010-08-26 | — | — | US | disclosed |
| US-20100213834-A1 | TRANSITION METAL COMPLEXES COMPRISING BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | BASF SE (DE) | 2010-08-26 | — | — | US | disclosed |
| US-7601436-B2 | a triazole ring containing carbene compound complexed with transitional metal; zwitterionic carbon donor ligand; | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-10-13 | — | — | US | disclosed |
| US-7601436-B2 | a triazole ring containing carbene compound complexed with transitional metal; zwitterionic carbon donor ligand; | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-10-13 | — | — | US | disclosed |
| WO-2009050281-A1 | TRANSITION METAL COMPLEXES WITH BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
| WO-2009050290-A1 | TRANSITION METAL COMPLEXES HAVING BRIDGED CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190189937-A1 | Carbene Metal Complexes as OLED Materials | OCIAD1, OCIAD2, OXA1L | ALOX12 157/4885HTR2C 2078/4885HTR2B 3381/4885 |
| US-10249834-B2 | Carbene metal complexes as OLED materials | OCIAD1, OCIAD2, OSTC | ALOX12 49/4885HTR2C 2698/4885HTR2B 3122/4885 |
| US-20160268518-A1 | Carbene Metal Complexes as OLED Materials | OCIAD1, OCIAD2, OXA1L | ALOX12 157/4885HTR2C 2078/4885HTR2B 3381/4885 |
| US-11778898-B2 | Carbene metal complexes as OLED materials | OCIAD1, OCIAD2, OSTC | ALOX12 54/4885HTR2C 2835/4885HTR2B 3310/4885 |
| US-20100213834-A1 | TRANSITION METAL COMPLEXES COMPRISING BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | OCIAD1, OCIAD2, OPRD1 | ALOX12 19/4885HTR2C 2602/4885HTR2B 1617/4885 |
| US-20120104378-A1 | CARBENE METAL COMPLEXES AS OLED MATERIALS | OCIAD1, OCIAD2, OXA1L | ALOX12 157/4885HTR2C 2078/4885HTR2B 3381/4885 |
| US-20100264405-A1 | TRANSITION METAL COMPLEXES WITH BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | OCIAD1, OCIAD2, OPRD1 | ALOX12 20/4885HTR2C 2608/4885HTR2B 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.